CapsoVision, Inc Increase (Decrease) in Accounts Receivable
CapsoVision, Inc (CV) reported Increase (Decrease) in Accounts Receivable of -$245.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- CapsoVision, Inc increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $349.00K, a 170.54% increase year-over-year.
- CapsoVision, Inc increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$594.00K.
- CapsoVision, Inc increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $629.00K, a 51.93% increase year-over-year.
- CapsoVision, Inc increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $16.00K.
- CapsoVision, Inc increase (decrease) in accounts receivable for fiscal 2025 was $478.00K, a 171.59% increase from fiscal 2024.
- CapsoVision, Inc increase (decrease) in accounts receivable for fiscal 2024 was $176.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $349.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$245.00K 10-Q · filed 2026-08-13 | $384.00K derived: sum of 3 quarters · filed 2026-08-13 | $400.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$594.00K 10-Q · filed 2026-05-14 | $35.00K derived: sum of 2 quarters · filed 2026-05-14 | $51.00K derived: sum of 3 quarters · filed 2026-05-14 | $180.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $629.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $645.00K derived: sum of 2 quarters · filed 2026-03-26 | $774.00K derived: sum of 3 quarters · filed 2026-08-13 | $478.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $145.00K derived: sum of 2 quarters · filed 2026-08-13 | -$151.00K 10-Q · filed 2025-11-13 | $263.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$167.00K 10-Q · filed 2026-08-13 | $247.00K derived: sum of 3 quarters · filed 2026-08-13 | $245.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$296.00K 10-Q · filed 2026-05-14 | $118.00K derived: sum of 2 quarters · filed 2026-05-14 | $116.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $412.00K derived: sum of 2 quarters · filed 2026-03-26 | $176.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$238.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$236.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |